Abstract P5-03-12: Signature-guided biomarker discovery and therapy for trastuzumab-resistant HER2-positive breast cancer

Yin, J ; Sand, A ; Sun, C ; Piacsek, M ; Beres, A ; Tjoe, JA

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P5-P5-03-12 [Periódico revisado por pares]

Texto completo disponível